WallStreetZenWallStreetZen

NASDAQ: IMMP
Immutep Ltd Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Be the first to know when Wall Street analysts revise their IMMP stock forecasts and price targets.

Forecast return on equity

Is IMMP forecast to generate an efficient return?

Company
0.47%
Industry
254.98%
Market
226.6%
IMMP's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is IMMP forecast to generate an efficient return on assets?

Company
0.43%
Industry
90.68%
IMMP is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

IMMP earnings per share forecast

What is IMMP's earnings per share in the next 3 years based on estimates from 5 analysts?

Avg 1 year Forecast
-$0.05
Avg 2 year Forecast
-$0.05
Avg 3 year Forecast
$0.00

IMMP revenue forecast

What is IMMP's revenue in the next 3 years based on estimates from 5 analysts?

Avg 1 year Forecast
$4.5M-33.13%
Avg 2 year Forecast
$4.5M-33.13%
Avg 3 year Forecast
$249.0M+3,562.96%
IMMP's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

IMMP revenue growth forecast

How is IMMP forecast to perform vs Biotechnology companies and vs the US market?

Company
213.56%
Industry
101.87%
Market
25.74%
IMMP's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
IMMP's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

IMMP vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
IMMP$2.63N/AN/A
CTNM$13.07$19.25+47.28%Strong Buy
VNDA$6.60$14.00+112.12%Strong Buy
CLLS$5.22$8.00+53.26%Strong Buy
LCTX$1.71$5.50+221.64%Strong Buy
View Top Biotech Stocks

Immutep Stock Forecast FAQ

What is IMMP's earnings growth forecast for 2026-2028?

(NASDAQ: IMMP) Immutep's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 44.21%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 42.48%.

Immutep's earnings in 2025 is -$39,892,314.On average, 5 Wall Street analysts forecast IMMP's earnings for 2026 to be -$78,130,842, with the lowest IMMP earnings forecast at -$84,410,517, and the highest IMMP earnings forecast at -$76,670,453. On average, 4 Wall Street analysts forecast IMMP's earnings for 2027 to be -$78,130,842, with the lowest IMMP earnings forecast at -$78,714,998, and the highest IMMP earnings forecast at -$76,670,453.

In 2028, IMMP is forecast to generate $438,117 in earnings, with the lowest earnings forecast at -$64,403,180 and the highest earnings forecast at $78,276,881.

If you're new to stock investing, here's how to buy Immutep stock.

What is IMMP's revenue growth forecast for 2026-2028?

(NASDAQ: IMMP) Immutep's forecast annual revenue growth rate of 213.56% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 101.87%, and it is also forecast to beat the US market's average forecast revenue growth rate of 25.74%.

Immutep's revenue in 2025 is $6,708,683.On average, 5 Wall Street analysts forecast IMMP's revenue for 2026 to be $6,637,470,618, with the lowest IMMP revenue forecast at $5,724,727,134, and the highest IMMP revenue forecast at $7,667,045,269. On average, 4 Wall Street analysts forecast IMMP's revenue for 2027 to be $6,637,470,618, with the lowest IMMP revenue forecast at $5,724,727,134, and the highest IMMP revenue forecast at $7,667,045,269.

In 2028, IMMP is forecast to generate $363,593,192,488 in revenue, with the lowest revenue forecast at $107,338,633,763 and the highest revenue forecast at $640,964,984,468.

What is IMMP's forecast return on assets (ROA) for 2026-2028?

(NASDAQ: IMMP) forecast ROA is 0.43%, which is lower than the forecast US Biotechnology industry average of 90.68%.

What is IMMP's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: IMMP) Immutep's current Earnings Per Share (EPS) is -$0.27. On average, analysts forecast that IMMP's EPS will be -$0.05 for 2026, with the lowest EPS forecast at -$0.06, and the highest EPS forecast at -$0.05. On average, analysts forecast that IMMP's EPS will be -$0.05 for 2027, with the lowest EPS forecast at -$0.05, and the highest EPS forecast at -$0.05. In 2028, IMMP's EPS is forecast to hit $0.00 (min: -$0.04, max: $0.05).

What is IMMP's forecast return on equity (ROE) for 2026-2028?

(NASDAQ: IMMP) forecast ROE is 0.47%, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.